Table 2.
Demographic and clinical description of the analyzed sample, comparing the ‘523’ S/S and VL/VL groups. No statistically-significant difference in any of the variables was found between the groups (S/S vs. VL/VL).
| Variable | All sample | %/SD | S/S | %/SD | VL/VL | %/SD |
|---|---|---|---|---|---|---|
| Number | 331 | 179 | 152 | |||
| Males (N) | 217 | 65.6% | 118 | 65.92% | 99 | 65.10% |
| Ashkenazi origin (N) | 211 | 63.7% | 118 | 65.92% | 93 | 61.18% |
| APOE ε2 allele carriers (N) | 47 | 14.2% | 28 | 15.64% | 19 | 12.50% |
| Age at cognitive evaluation | 71.98 | 4.87 | 72.44 | 5.03 | 71.43 | 4.63 |
| Years of education | 13.36 | 3.18 | 13.16 | 3.15 | 13.60 | 3.21 |
| Hemoglobin A1c (mean) | 6.79 | 0.82 | 6.76 | 0.78 | 6.83 | 0.86 |
| Creatinine (mean) | 1.01 | 0.27 | 1.01 | 0.23 | 1.00 | 0.31 |
| BMI (mean) | 28.85 | 4.71 | 28.80 | 4.60 | 28.91 | 4.85 |
| Total cholesterol (mean) | 181.49 | 23.10 | 181.78 | 23.35 | 181.15 | 22.89 |
| HDL (mean) | 47.62 | 10.24 | 47.76 | 9.97 | 47.45 | 10.58 |
| LDL (mean) | 103.11 | 18.36 | 103.36 | 18.47 | 102.83 | 18.29 |
| Triglyceride (mean) | 155.36 | 56.25 | 155.59 | 54.77 | 155.09 | 58.13 |
| Duration of disease (years) | 10.62 | 0.85 | 10.61 | 0.74 | 10.64 | 0.98 |
| Diastolic BP (mean) | 85.02 | 16.10 | 83.54 | 15.37 | 86.76 | 16.79 |
| Systolic BP (mean) | 166.68 | 9.70 | 165.79 | 9.93 | 167.72 | 9.34 |